Quantitative Systematic Strategies’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Quantitative Systematic Strategies’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,200	Closed	-$234K	–	863
2018 Q2	$234K	Buy	+6,200	New	+$237K	0.04%	523
2016 Q1	–	Sell	-5,899	Closed	-$305K	–	886
2015 Q4	$305K	Buy	+5,899	New	+$286K	0.08%	515
2015 Q2	–	Sell	-21,342	Closed	-$819K	–	645
2015 Q1	$819K	Buy	+21,342	New	+$733K	0.22%	139

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Quantitative Systematic Strategies's PTLA Position: Q3 2018 in Review

Quantitative Systematic Strategies sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018, closing a stake of 6,200 shares — an estimated $234K sold.

Quantitative Systematic Strategies first reported a position in PTLA in Q1 2015 and held it in 3 quarters. The position peaked at $819K in Q1 2015. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

Quantitative Systematic Strategies reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Quantitative Systematic Strategies sold 6,200 Portola Pharmaceuticals, Inc. shares in Q3 2018, an estimated $234K.
Quantitative Systematic Strategies first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
Quantitative Systematic Strategies's Portola Pharmaceuticals, Inc. position peaked at $819K in Q1 2015.
197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.